Nauck, Friedemann

[["dc.bibliographiccitation.firstpage","395"],["dc.bibliographiccitation.issue","06"],["dc.bibliographiccitation.journal","Frauenheilkunde up2date"],["dc.bibliographiccitation.lastpage","406"],["dc.bibliographiccitation.volume","7"],["dc.contributor.author","Nauck, Friedemann"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.date.accessioned","2022-02-21T16:45:07Z"],["dc.date.available","2022-02-21T16:45:07Z"],["dc.date.issued","2013"],["dc.identifier.doi","10.1055/s-0033-1346910"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/100165"],["dc.language.iso","de"],["dc.relation.issn","1439-3719"],["dc.relation.issn","1611-650X"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Palliativmedizinische Aspekte in der Gynäkologie"],["dc.title.subtitle","Behandlung und Begleitung schwerkranker und sterbender Patientinnen"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2297"],["dc.bibliographiccitation.issue","45"],["dc.bibliographiccitation.journal","DMW - Deutsche Medizinische Wochenschrift"],["dc.bibliographiccitation.lastpage","2301"],["dc.bibliographiccitation.volume","136"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.contributor.author","Suerig, R."],["dc.contributor.author","Lindena-Gläß, Gabriele"],["dc.contributor.author","Nauck, Friedemann"],["dc.date.accessioned","2018-11-07T08:50:16Z"],["dc.date.available","2018-11-07T08:50:16Z"],["dc.date.issued","2011"],["dc.description.abstract","How much diagnostics is required in palliative care? Results from a representative survey and own experiences Background: Applying diagnostic techniques in palliative care (PC) requires a thorough balance between a physical, psychosocial (and financial) burden and its therapeutic relevance in far advanced diseases. The extent of diagnostic employment in PC, preferred techniques, application problems, its informative value and therapeutic significance still have to be described. Methods: The Hospice and Palliative Care Evaluation (HOPE) 2007 collected data from the application of microbiological and imaging techniques in German PC institutions. Furthermore, 70 consecutive ultrasound scans in our PC unit have been retrospectively analyzed. In 691 PC patients (from a total of 3184 in HOPE), diagnostic techniques (DIA) were applied and documented. Results: In-patients with DIA (86,1%) and the HOPE collective showed a comparable age and duration of hospital stay. Microbiological techniques contributed to 26,1% of all documented in-patient investigations, imaging techniques 69,1%. Ultrasound was the preferred imaging technique on PC units (67,1%), whilst radiography, CT or MRI scans were rather employed on oncology wards. Nuclear imaging was rarely documented. In 80,8%, imaging diagnostics were considered relevant for further treatment decisions (inpatients only); transportation problems and pain during imaging were relevant obstacles. In our own patient cohort, ultrasound was applied rather for general prognostic purposes, less often resulting in immediate therapeutic actions. Transportation problems could be almost entirely avoided by using a mobile ultrasound device. Conclusion: DIA in PC are applied independently of age or duration of hospital stay; its therapeutic significance is considered to be high; procedural problems may be resolvable. Therefore, this survey might challenge the tradition of low technology in PC."],["dc.identifier.doi","10.1055/s-0031-1292042"],["dc.identifier.isi","000296724600005"],["dc.identifier.pmid","22048934"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/21659"],["dc.language.iso","de"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.issn","0012-0472"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Wieviel Diagnostik braucht die Palliativmedizin? Ergebnisse einer multizentrischen Studie und Fallserie"],["dc.title.alternative","How much diagnostics is required in palliative care? Results from a representative survey and own experiences"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","255"],["dc.bibliographiccitation.issue","06"],["dc.bibliographiccitation.journal","Zeitschrift für Palliativmedizin"],["dc.bibliographiccitation.lastpage","256"],["dc.bibliographiccitation.volume","17"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.contributor.author","Radbruch, Lukas"],["dc.contributor.author","Nauck, Friedemann"],["dc.date.accessioned","2022-02-21T12:48:01Z"],["dc.date.available","2022-02-21T12:48:01Z"],["dc.date.issued","2016"],["dc.identifier.doi","10.1055/s-0042-118124"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/100145"],["dc.language.iso","de"],["dc.relation.issn","1615-2921"],["dc.relation.issn","1615-293X"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Freiwilliger Verzicht auf Nahrung und Flüssigkeit – mehr Fragen als Antworten"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","842"],["dc.bibliographiccitation.issue","8"],["dc.bibliographiccitation.journal","Geburtshilfe und Frauenheilkunde"],["dc.bibliographiccitation.lastpage","844"],["dc.bibliographiccitation.volume","68"],["dc.contributor.author","Nauck, Friedemann"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.date.accessioned","2022-03-17T19:16:20Z"],["dc.date.available","2022-03-17T19:16:20Z"],["dc.date.issued","2008"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/104821"],["dc.language.iso","de"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Palliativmedizinische Konzepte in der Gynäkologie"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","430"],["dc.bibliographiccitation.issue","4-5"],["dc.bibliographiccitation.journal","Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],["dc.bibliographiccitation.lastpage","435"],["dc.bibliographiccitation.volume","58"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.contributor.author","Nauck, F."],["dc.date.accessioned","2018-11-07T09:58:58Z"],["dc.date.available","2018-11-07T09:58:58Z"],["dc.date.issued","2015"],["dc.description.abstract","Specialized palliative home care (\"Spezialisierte Ambulante Palliativversorgung\", SAPV) denotes an intensified, multi-professional support system at home for patients suffering from complex symptoms and needs associated with severe and advanced illness. In 2007, a change in legislation guaranteed SAPV to any patient (covered by public health insurance) in need of specialized palliative care. Despite further specifications by federal institutions, SAPV has been transferred into German clinical practice in a very regionally diverse manner. This contribution describes the legislative and conceptual framework of SAPV, the financial and clinical aspects, and its future perspectives for the comprehensive palliative care of patients with complex demands."],["dc.identifier.doi","10.1007/s00103-015-2125-6"],["dc.identifier.isi","000353056800012"],["dc.identifier.pmid","25673015"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/37478"],["dc.language.iso","de"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.relation.issn","1437-1588"],["dc.relation.issn","1436-9990"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Spezialisierte Ambulante Palliativversorgung (SAPV). Vernetzung von Sektoren, Disziplinen und Professionen"],["dc.title.alternative","Specialized palliative home care. An interprofessional network"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","633"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Der Schmerz"],["dc.bibliographiccitation.lastpage","639"],["dc.bibliographiccitation.volume","24"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.contributor.author","Nauck, F."],["dc.date.accessioned","2018-11-07T08:36:34Z"],["dc.date.available","2018-11-07T08:36:34Z"],["dc.date.issued","2010"],["dc.description.abstract","In modern oncology, paradigmatic developments can be witnessed with respect to conceptual strategies and to individualized diagnostics and treatment approaches, but foremost with respect to the amazing number of new anticancer substances available. These developments will certainly influence the care of patients suffering from incurable and advanced cancer, where pain therapy and symptom control, quality of life and other intentions of palliative care are urgent. For cancer pain therapy and palliative care, knowledge about these developments may be helpful not only with respect to interdisciplinary decision making, but also for thoroughly balancing risks, side effects and benefits of oncological interventions that have the potential to stabilize disease progression and thereby reduce symptom intensity."],["dc.identifier.doi","10.1007/s00482-010-0940-0"],["dc.identifier.isi","000284958500013"],["dc.identifier.pmid","20882301"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/18341"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.relation.issn","0932-433X"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Implications of modern anticancer therapies for palliative care concepts"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","617"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Journal of Pain and Symptom Management"],["dc.bibliographiccitation.lastpage","625"],["dc.bibliographiccitation.volume","52"],["dc.contributor.author","Simon, Steffen T."],["dc.contributor.author","Kloke, Marianne"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.contributor.author","Gaertner, Jan"],["dc.contributor.author","Hellmich, Martin"],["dc.contributor.author","Hein, Rebecca"],["dc.contributor.author","Piel, Maren"],["dc.contributor.author","Cornely, Oliver A."],["dc.contributor.author","Nauck, Friedemann"],["dc.contributor.author","Voltz, Raymond"],["dc.date.accessioned","2018-11-07T10:06:21Z"],["dc.date.available","2018-11-07T10:06:21Z"],["dc.date.issued","2016"],["dc.description.abstract","Context. Episodic breathlessness is a frequent and burdensome symptom in cancer patients but pharmacological treatment is limited. Objectives. To determine time to onset, efficacy, feasibility, and safety of transmucosal fentanyl in comparison to immediate-release morphine for the relief of episodic breathlessness. Methods. Phase II, investigator-initiated, multicenter, open-label, randomized, morphine-controlled, crossover trial with openlabel titration of fentanyl buccal tablet (FBT) in inpatients with incurable cancer. The primary outcome was time to onset of meaningful breathlessness relief. Secondary outcomes were efficacy (breathlessness intensity difference at 10 and 30 minutes; sum of breathlessness intensity difference at 15 and 60 minutes), feasibility, and safety. Study was approved by local ethics committees. Results. Twenty-five of 1341 patients were eligible, 10 patients agreed to participate (four female, mean age 58 +/- 11, mean Karnofsky score 67 +/- 11). Two patients died before final visits and two patients dropped-out because of disease progression leaving six patients for analysis with 61 episodes of breathlessness. Mean time to onset was for FBT 12.7 +/- 10.0 and for immediate-release morphine 23.6 +/- 15.1 minutes with a mean difference of -10.9 minutes (95% CI - -24.5 to 2.7, P = 0.094). Efficacy measures were predominately in favor for FBT. Both interventions were safe. Feasibility failed because of too much study demands for a very ill patient group. Conclusion. The description of a faster and greater relief of episodic breathlessness by transmucosal fentanyl versus morphine justifies further evaluation by a full-powered trial. (C) 2016 Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine."],["dc.identifier.doi","10.1016/j.jpainsymman.2016.05.023"],["dc.identifier.isi","000387961500005"],["dc.identifier.pmid","27693898"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/39078"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Inc"],["dc.relation.issn","1873-6513"],["dc.relation.issn","0885-3924"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","12"],["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","GMS Zeitschrift für medizinische Ausbildung"],["dc.bibliographiccitation.lastpage","12"],["dc.bibliographiccitation.volume","29"],["dc.contributor.author","Ilse, B."],["dc.contributor.author","Hildebrandt, J."],["dc.contributor.author","Posselt, J."],["dc.contributor.author","Laske, A."],["dc.contributor.author","Dietz, I."],["dc.contributor.author","Borasio, G. D."],["dc.contributor.author","Kopf, A."],["dc.contributor.author","Nauck, F."],["dc.contributor.author","Elsner, F."],["dc.contributor.author","Wedding, U."],["dc.contributor.author","Alt-Epping, B."],["dc.date.accessioned","2019-07-10T08:14:07Z"],["dc.date.available","2019-07-10T08:14:07Z"],["dc.date.issued","2012"],["dc.description.abstract","Fragestellung: Mit der Änderung der ärztlichen Approbationsordnung (ÄApprO) im Jahre 2009 wurde die Palliativmedizin als 13. Querschnittsfach (Q13) verpflichtend in das studentische Curriculum eingeführt. Die Umsetzung dieser Änderung muss bis zum Beginn des Praktischen Jahres im August 2013 oder bei der Meldung zum Zweiten Abschnitt der Ärztlichen Prüfung für den Prüfungstermin im Oktober 2014 erfolgen. In vorangegangenen Umfragen wurden an den medizinischen Fakultäten in Deutschland sehr heterogene palliativmedizinische Lehrstrukturen beschrieben. Daher sollten nun die curricularen und prüfungsbezogenen Planungen der jeweiligen Fakultäten zur Implementierung eines verpflichtenden Q13 Palliativmedizin erfragt werden. Methodik: Die Bundesvertretung der Medizinstudierenden Deutschlands (bvmd) führt seit 2006 zweijährliche Umfragen an allen medizinischen Fakultäten in Deutschland zum gegenwärtigen Stand der palliativmedizinischen Lehre durch. Nach Konzeption eines Online-Fragebogens und Pilotierung erfolgte im Mai 2010 eine einmonatige Online-Umfrage. Die Daten wurden deskriptiv ausgewertet. Ergebnisse: 31 von 36 medizinischen Fakultäten nahmen an der Befragung teil. An 15 Fakultäten existierten zum Befragungszeitpunkt bereits verpflichtende Lehrveranstaltungen entsprechend der Vorgabe der neuen ÄApprO; an drei Standorten soll das Q13 Palliativmedizin erst ab dem Sommersemester 2012 verpflichtend eingeführt werden. An 15 Fakultäten bestand bereits ein Lehrcurriculum für Q13, teils angelehnt an die curricularen Vorgaben der Deutschen Gesellschaft für Palliativmedizin. Sechs Standorte beschrieben einen begonnenen Implementierungsprozess noch ohne Curriculum. An den meisten Fakultäten werden 21-40 Lehrveranstaltungsstunden angestrebt, die überwiegend in Form von Vorlesungen oder Seminaren, seltener auch in betreuungsintensiveren Formaten angeboten werden sollen. Die Mehrzahl der teilnehmenden Fakultäten strebt eine Prüfung in Form von Multiple Choice Fragen an. An 8 Universitäten bestand ein eigenständiger Lehrstuhl für Palliativmedizin (5 weitere in Planung); dies war mit einem höheren Maß an Pflichtlehre analog der Vorgabe der ÄApprO verbunden. Ein breites Spektrum an lehrbeteiligten Berufsgruppen, Fachdisziplinen und externen Kooperationspartnern wurde angegeben. Schlussfolgerung: Die infrastrukturellen Voraussetzungen, die bisherigen curricularen Planungen und der Grad der Implementierung des Q13 analog der Vorgabe der neuen ÄApprO divergieren zwischen den einzelnen medizinischen Fakultäten erheblich. Die Bemühungen um eine qualitativ hochwertige Lehre in Hinblick auf die vielschichtigen Fragestellungen bei der Betreuung schwerst- und sterbenskranker Patienten spiegeln sich in der Umfrage ebenso wider wie der besondere Stellenwert eines eigenständigen Lehrstuhls für Palliativmedizin für die Umsetzung der gesetzlichen Vorgaben. Die Mitwirkung der verschiedenen Berufsverbände an dieser Umfrage sowie das große Spektrum der Lehrbeteiligten unterstreicht die interdisziplinäre und multiprofessionelle Dimension palliativmedizinischer Lehre."],["dc.identifier.fs","591769"],["dc.identifier.pmid","22737202"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/9539"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/61440"],["dc.language.iso","de"],["dc.notes.intern","Merged from goescholar"],["dc.relation.issn","1860-3572"],["dc.relation.orgunit","Universitätsmedizin Göttingen"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.subject.ddc","610"],["dc.title","Palliativmedizinische Lehre in Deutschland – Planungen der Fakultäten zum zukünftigen Querschnittsfach 13"],["dc.title.translated","Palliative Care teaching in Germany – concepts and future developments"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","273"],["dc.bibliographiccitation.lastpage","282"],["dc.contributor.author","Nauck, Friedemann"],["dc.contributor.author","Alt-Epping, Bernd"],["dc.date.accessioned","2022-04-19T14:47:33Z"],["dc.date.available","2022-04-19T14:47:33Z"],["dc.date.issued","2010"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/106566"],["dc.language.iso","de"],["dc.publisher","Thieme"],["dc.publisher.place","Stuttgart [u.a.]"],["dc.relation.ispartof","Anästhesie bei alten Menschen"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Palliativmedizin"],["dc.type","book_chapter"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","221"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Zeitschrift für Palliativmedizin"],["dc.bibliographiccitation.volume","9"],["dc.contributor.author","Nauck, Friedemann"],["dc.contributor.author","Eulitz, N."],["dc.contributor.author","Geyer, A."],["dc.contributor.author","Alt-Epping, Bernd"],["dc.date.accessioned","2022-03-17T19:16:28Z"],["dc.date.available","2022-03-17T19:16:28Z"],["dc.date.issued","2008"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/104823"],["dc.language.iso","de"],["dc.relation.orgunit","Klinik für Palliativmedizin"],["dc.title","Durchbruchschmerzen. Epidemiologie, Charakteristik und Therapie unter Berücksichtigung verschiedener Applikationsformen starker Opioide"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]